1006614-50-1

Basic information

• Product Name: (1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid
• CAS NO: 1006614-50-1
• Molecular Weight: 198.169
• Mol File: 1006614-50-1.mol
• Article Data: 29

Chemical Properties

• CAS DataBase Reference: (1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid(1006614-50-1)
• EPA Substance Registry System: (1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid(1006614-50-1)

Safety Data

• Hazardous Substances Data: 1006614-50-1(Hazardous Substances Data)

Usage

Description

(1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid is a chemical compound characterized by a cyclopropylcarboxylic acid structure with a molecular formula of C11H9F2O2 and a molecular weight of 212.188 g/mol. (1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid features a 3,4-difluorophenyl group attached to the cyclopropyl ring, which may contribute to its chemical and physical properties, as well as its interaction with biological targets. Due to its structural features and potential biological activities, it has promising pharmaceutical applications.

Uses

Used in Pharmaceutical Industry:
(1R,2R)-2-(3,4-difluorophenyl)cyclopropylcarboxylic acid is used as a pharmaceutical compound for its potential analgesic, anti-inflammatory, or antimicrobial properties. Its unique structure and the presence of the 3,4-difluorophenyl group may enhance its efficacy and selectivity in targeting specific biological pathways or receptors, making it a valuable candidate for the development of new drugs and therapies.

Upstream product

• 64248-58-4 1,2-difluoro-4-iodo-benzene 
• 893747-16-5 3,4-difluorobenzeneprop-2-ynol 
• 1006376-63-1 (S)-2-(3,4-difluorophenyl)ethylene oxide 
• 1006376-60-8 (1S)-2-chloro-1-(3,4-difluorophenyl)-1-ethanol 
• 1459719-83-5 (E)-3-(3,4-difluorophenyl)acrylonitrile 
• 34036-07-2 3,4 difluorobenzaldehyde 
• 1421708-29-3 (E)-3-(3,4-difluorophenyl)-N-methoxy-N-methyl-prop-2-enamide 
• 376608-66-1 (E)-3-(3,4-difluorophenyl)acryloyl chloride 
• 112897-97-9 (E)-3-(3,4-difluorophenyl)acrylic acid 
• 218430-47-8 (E)-methyl 3-(3,4-difluorophenyl)acrylate 
• 84313-94-0 4-(3,4-difluorophenyl)-4-oxopropionic acid 
• 1450897-33-2 4-(3,4-difluorophenyl)-4-hydroxybutanenitrile 
• 367-11-3 ortho-difluorobenzene 

Downstream Products

• 1459720-02-5 (1R,2S)-2-(3,4-difluorophenyl)cyclopropanoic acid methyl ester 
• 1459720-05-8 (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbohydrazide 
• 378236-67-0 (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide 
• 1350749-64-2 tert-butyl ((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)carbamate 
• 1402222-66-5 trans-(1R,2S)-2-(3,4-difluorophenyl)cyclopropylamine hydrochloride 
• 1006614-49-8 trans-2-(3,4-difluorophenyl)cyclopropanamine 
• 376608-71-8 trans-(1R,2S)-2-(3,4-difluorophenyl)cyclopropylamine (2R)-2-hydroxy-2-phenylacetic acid salt 
• 2096989-55-6 [1S-[1a,2a,3β(1S*,2R*),5B]]-3-[7-[2-(3,4-difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol 

Relevant articles and documents

Preparation method of phenyl-containing compound

The present invention discloses a method for preparing an phenyl-containing compound. The present invention provides a method for preparing a compound shown in formula I, comprising the following steps: in the presence of formamide or acetamide, in the pr

Preparation method of ticagrelor key intermediate

The invention belongs to the technical field of medicines, and particularly relates to a preparation method of a ticagrelor key intermediate, and the method is used for preparing the ticagrelor intermediate, has the advantages of short reaction steps, mild reaction conditions and higher yield than the existing preparation method, is economical and effective, and is suitable for large-scale industrial production.

Preparation method of ticagrelor

The invention discloses a preparation method of ticagrelor. The preparation method comprises the following steps: (1) preparation of ticagrelor intermediate product 1-TK acid; (2) preparation of ticagrelor intermediate product 2-TK-amide; (3) preparation of ticagrelor intermediate product 3-TK-amino compound hydrochloride; (4) preparation of ticagrelor intermediate product 4-TK-amino compound R-tartrate; ( 5) preparation of ticagrelor intermediate product 5-TK-amino compound L-mandelate; and (6) preparation of ticagrelor-TK. The preparation method has the advantages of cost advantage, mature and stable process, stable product quality, and safe and reliable production process.